Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Tunis Med ; 96(1): 68-71, 2018 Jan.
Article in English | MEDLINE | ID: mdl-30324996

ABSTRACT

Sclerosing encapsulating peritonitis (SEP) is a rare and little known pathological entity. It is a chronic fibro-inflammatory disease of the peritoneum, resulting in the formation of a thick fibrous membrane, which engages partially or totally the abdominal organs. Clinical and radiological signs make the diagnosis difficult to establish preoperatively. We present two original observations of SEP illustrating different clinical presentations, diagnostic and therapeutic means. His diagnosis requires a peritoneal biopsy. The treatment is not completely established. Surgical treatment is difficult, involving viscerolysis and multiple incisions of the fibrous membrane. Despite the current progress in therapeutic management, the prognosis remains pejorative, with significant mortality.


Subject(s)
Peritoneal Fibrosis/diagnosis , Peritonitis/diagnosis , Abdominal Pain/diagnosis , Abdominal Pain/etiology , Abdominal Pain/surgery , Adult , Digestive System Surgical Procedures , Humans , Intestinal Obstruction/diagnosis , Intestinal Obstruction/etiology , Intestinal Obstruction/surgery , Male , Middle Aged , Peritoneal Fibrosis/complications , Peritoneal Fibrosis/surgery , Peritonitis/complications , Peritonitis/surgery
2.
J Clin Diagn Res ; 11(9): PD14-PD16, 2017 Sep.
Article in English | MEDLINE | ID: mdl-29207779

ABSTRACT

Intraductal Tubulopapillary Neoplasms (ITPN) is a rare and new entity defined as an intraductal, grossly visible, tubule-forming epithelial neoplasm with high- grade dysplasia and ductal differentiation without overt production of mucin. Its clinical presentation can be varied, which makes the diagnosis quite challenging. In this report, we present a case of pancreatic ITPN and review the published work to learn clinicopathological, radiological features and treatment strategies of this recently proposed pancreatic neoplasm.

3.
Pan Afr Med J ; 28: 80, 2017.
Article in French | MEDLINE | ID: mdl-29255550

ABSTRACT

Drug-induced acute pancreatitis (AP) accounts for approximately 2% of acute pancreatitis. Its incidence is increasing, with more than 260 incriminated drugs. However, very few cases have been described in the literature due to accountability problem. We report our experience with 10 cases whose data were collected over a period of 7 years. Clinical presentation of AP was often equivocal. Ranson's score ranged from 0 to 5. We recorded 5 cases of edematous pancreatitis and 5 cases of necro-bleeding pancreatitis. These pancreatitis were often successfully treated without recurrence after discontinuation of the incriminated drug.


Subject(s)
Edema/chemically induced , Pancreatitis, Acute Necrotizing/chemically induced , Pancreatitis/chemically induced , Acute Disease , Edema/pathology , Humans , Pancreatitis/pathology , Pancreatitis, Acute Necrotizing/pathology , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...